Baxter - 39 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1981 adjusted for splits. The latest closing stock price for Baxter as of January 22, 2020 is 91.16.
- The all-time high Baxter stock closing price was 91.16 on January 22, 2020.
- The Baxter 52-week high stock price is 91.86, which is 0.8% above the current share price.
- The Baxter 52-week low stock price is 69.86, which is 23.4% below the current share price.
- The average Baxter stock price for the last 52 weeks is 80.96.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2020 | 87.9579 | 85.8700 | 91.1600 | 85.2900 | 91.1600 | 9.02% |
| 2019 | 79.7233 | 65.3000 | 89.7800 | 64.4800 | 83.6200 | 27.04% |
| 2018 | 69.8944 | 67.1700 | 77.8000 | 61.4500 | 65.8200 | 1.83% |
| 2017 | 58.0264 | 44.4400 | 66.0500 | 44.4400 | 64.6400 | 45.78% |
| 2016 | 43.8994 | 37.1700 | 49.1600 | 34.7600 | 44.3400 | 16.23% |
| 2015 | 52.9969 | 73.3100 | 73.3100 | 32.2700 | 38.1500 | -47.95% |
| 2014 | 72.2730 | 69.1900 | 77.0000 | 66.4900 | 73.2900 | 5.38% |
| 2013 | 69.3542 | 67.6500 | 74.4300 | 63.8900 | 69.5500 | 4.34% |
| 2012 | 58.0275 | 50.5400 | 68.8100 | 49.0300 | 66.6600 | 34.72% |
| 2011 | 54.3502 | 50.5500 | 62.4100 | 47.6500 | 49.4800 | -2.25% |
| 2010 | 49.9003 | 58.2900 | 61.7100 | 40.4700 | 50.6200 | -13.74% |
| 2009 | 54.0204 | 55.0800 | 60.5000 | 46.4100 | 58.6800 | 9.50% |
| 2008 | 61.4454 | 57.7900 | 71.1500 | 48.5000 | 53.5900 | -7.68% |
| 2007 | 54.7795 | 46.5000 | 61.0900 | 46.3300 | 58.0500 | 25.13% |
| 2006 | 40.9353 | 38.3600 | 47.2100 | 35.4500 | 46.3900 | 23.21% |
| 2005 | 37.2682 | 34.6200 | 40.9500 | 33.3700 | 37.6500 | 9.00% |
| 2004 | 31.4834 | 30.1700 | 34.5900 | 28.7600 | 34.5400 | 13.17% |
| 2003 | 26.5794 | 28.6900 | 31.2000 | 18.5600 | 30.5200 | 9.00% |
| 2002 | 43.1442 | 53.1000 | 59.6000 | 24.2200 | 28.0000 | -47.79% |
| 2001 | 48.4272 | 44.8150 | 55.5000 | 40.7500 | 53.6300 | 21.46% |
| 2000 | 35.8150 | 30.6900 | 44.4400 | 25.9050 | 44.1550 | 40.60% |
| 1999 | 32.7239 | 31.5950 | 37.9700 | 29.3450 | 31.4050 | -2.24% |
| 1998 | 28.6442 | 25.0650 | 33.0000 | 24.3450 | 32.1250 | 27.38% |
| 1997 | 25.1378 | 20.3150 | 29.7500 | 20.3150 | 25.2200 | 23.02% |
| 1996 | 21.9332 | 20.8100 | 23.9375 | 20.0000 | 20.5000 | -2.10% |
| 1995 | 17.7909 | 14.0650 | 21.2500 | 13.5650 | 20.9400 | 46.95% |
| 1994 | 12.7748 | 12.1900 | 14.3150 | 11.0000 | 14.2500 | 16.90% |
| 1993 | 13.4814 | 15.9400 | 15.9400 | 10.1250 | 12.1900 | -24.71% |
| 1992 | 17.9988 | 19.6250 | 20.0650 | 15.3750 | 16.1900 | -19.05% |
| 1991 | 16.9144 | 13.6900 | 20.1900 | 12.8150 | 20.0000 | 43.47% |
| 1990 | 12.3140 | 12.7500 | 14.5000 | 10.3150 | 13.9400 | 11.52% |
| 1989 | 10.7476 | 8.8100 | 12.8100 | 8.8100 | 12.5000 | 41.88% |
| 1988 | 10.3560 | 11.6850 | 12.9350 | 8.2500 | 8.8100 | -22.55% |
| 1987 | 12.1138 | 9.5000 | 14.5600 | 9.1850 | 11.3750 | 18.18% |
| 1986 | 9.0744 | 7.7500 | 10.5600 | 7.6250 | 9.6250 | 22.22% |
| 1985 | 7.3046 | 6.5650 | 8.3100 | 6.2500 | 7.8750 | 19.95% |
| 1984 | 8.1495 | 11.6250 | 12.2500 | 6.0000 | 6.5650 | -43.53% |
| 1983 | 13.3763 | 11.5925 | 15.6575 | 10.6850 | 11.6250 | -3.89% |
| 1982 | 9.6983 | 8.5625 | 12.6250 | 7.8125 | 12.0950 | 44.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $46.542B | $11.127B |
| Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $162.450B | 28.35 |
| Medtronic (MDT) | Ireland | $162.306B | 22.42 |
| Stryker (SYK) | United States | $81.207B | 27.30 |
| Boston Scientific (BSX) | United States | $61.398B | 28.98 |
| Essilor Luxottica (ESLOY) | France | $33.935B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $31.054B | 19.48 |
| Lonza Group Ag (LZAGY) | Switzerland | $30.726B | 0.00 |
| Terumo (TRUMY) | Japan | $27.631B | 34.48 |
| Coloplast (CLPBY) | Denmark | $27.475B | 42.40 |
| ResMed (RMD) | United States | $23.636B | 43.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $21.789B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $20.017B | 0.00 |
| Insulet (PODD) | United States | $11.820B | 562.35 |
| Bio-Rad Laboratories (BIO) | United States | $11.331B | 54.38 |
| Canopy Growth (CGC) | Canada | $8.412B | 0.00 |
| Perrigo (PRGO) | Ireland | $8.096B | 15.10 |
| William Demant Holdings (WILYY) | Denmark | $7.896B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.608B | 22.37 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.357B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $6.158B | 31.81 |
| Haemonetics (HAE) | United States | $5.859B | 39.59 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| NuVasive (NUVA) | United States | $4.053B | 31.92 |
| ICU Medical (ICUI) | United States | $4.016B | 26.18 |
| Neogen (NEOG) | United States | $3.682B | 61.28 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.537B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.427B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.169B | 0.00 |
| Quidel (QDEL) | United States | $3.142B | 29.82 |
| National Vision Holdings (EYE) | United States | $2.772B | 62.57 |
| Aurora Cannabis (ACB) | Canada | $2.223B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.893B | 0.00 |
| AtriCure (ATRC) | United States | $1.510B | 0.00 |
| InMode (INMD) | Israel | $1.476B | 0.00 |
| Aphria (APHA) | $1.443B | 0.00 | |
| TG Therapeutics (TGTX) | United States | $1.341B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.194B | 23.86 |
| NanoString Technologies (NSTG) | United States | $1.061B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 19.38 |
| PetIQ (PETQ) | United States | $0.857B | 20.90 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.792B | 30.32 |
| Lantheus Holdings (LNTH) | United States | $0.736B | 18.39 |
| LeMaitre Vascular (LMAT) | United States | $0.736B | 41.36 |
| Quanterix (QTRX) | United States | $0.710B | 0.00 |
| Omeros (OMER) | United States | $0.672B | 0.00 |
| Cerus (CERS) | United States | $0.603B | 0.00 |
| MacroGenics (MGNX) | United States | $0.575B | 0.00 |
| Surmodics (SRDX) | United States | $0.563B | 58.31 |
| OraSure Technologies (OSUR) | United States | $0.504B | 30.26 |
| Organigram Holdings (OGI) | Canada | $0.477B | 0.00 |
| Owens & Minor (OMI) | United States | $0.423B | 15.65 |
| Meridian Bioscience (VIVO) | United States | $0.419B | 14.38 |
| HEXO (HEXO) | $0.389B | 0.00 | |
| Utah Medical Products (UTMD) | United States | $0.388B | 28.14 |
| Zynex (ZYXI) | United States | $0.348B | 39.37 |
| BioLife Solutions (BLFS) | United States | $0.311B | 126.67 |
| Female Health (VERU) | United States | $0.297B | 0.00 |
| Bovie Medical (APYX) | United States | $0.283B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.282B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.250B | 0.00 |
| Vapotherm (VAPO) | United States | $0.246B | 0.00 |
| United Health Products (UEEC) | United States | $0.229B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.213B | 22.40 |
| Liberty Health Sciences (LHSIF) | Canada | $0.180B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.175B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.173B | 874.00 |
| Rockwell Medical (RMTI) | United States | $0.168B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.149B | 0.00 |
| Fonar (FONR) | United States | $0.134B | 9.48 |
| Chimerix (CMRX) | United States | $0.123B | 0.00 |
| Surface Oncology (SURF) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.093B | 0.00 |
| United-Guardian (UG) | United States | $0.083B | 21.10 |
| MRI Interventions (MRIC) | United States | $0.079B | 0.00 |
| Nephros (NEPH) | United States | $0.076B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.068B | 0.00 |
| FSD PHARMA INC (HUGE) | $0.053B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.030B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.025B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.016B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.015B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.008B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.006B | 0.00 |
| Myomo (MYO) | United States | $0.005B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
